Autonomy Capital (Jersey)’s Genmab GMAB Stock Holding History

Autonomy Capital (Jersey)’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-57,968	Closed	-$2.37M	–	32
2021 Q2	$2.37M	Buy	57,968 +810	+1%	+$31.3K	0.72%	21
2021 Q1	$1.88M	Sell	57,158 -1,196	-2%	-$45K	0.18%	4
2020 Q4	$2.37M	Buy	+58,354	New	+$2.18M	0.38%	12

Other funds holding GMAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Autonomy Capital (Jersey)'s GMAB Position: Q3 2021 in Review

Autonomy Capital (Jersey) sold out of Genmab (GMAB) in Q3 2021, closing a stake of 57,968 shares — an estimated $2.37M sold.

Autonomy Capital (Jersey) first reported a position in GMAB in Q4 2020 and held it in 3 quarters. The position peaked at $2.37M in Q4 2020. 211 funds tracked by Wall St. Rank hold GMAB as of Q3 2021.

Autonomy Capital (Jersey) reported no remaining Genmab position as of Q3 2021 after selling out during the quarter.
Autonomy Capital (Jersey) sold 57,968 Genmab shares in Q3 2021, an estimated $2.37M.
Autonomy Capital (Jersey) first reported a position in Genmab in Q4 2020 and held it in 3 quarters.
Autonomy Capital (Jersey)'s Genmab position peaked at $2.37M in Q4 2020.
211 funds tracked by Wall St. Rank held Genmab as of Q3 2021.

Based on Autonomy Capital (Jersey)'s 13F filing for Q3 2021, filed 12 Nov 2021.